Developing a diverse portfolio of vaccine candidates for Rift Valley Fever, Chikungunya and Ebola

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

SAC minutes

Summary of Scientific Advisory Committee meetings

Final periodic report to the EC

Final periodic report to the EC, containing deliverables

Budget templates

Budget templates for awardees to complete

List of communication activities conducted, period 2

List of main communication activities conducted, period 2

List of communication activities conducted, period 4

List of main communication activities conducted, period 4

Project description template

CEPI's project description template for awardees

List of communication activities conducted, period 3

List of main communication activities conducted period 3

3rd periodic report to the EC

3rd periodic report to the EC containing deliverables

2nd periodic report to the EC

2nd periodic report to the EC , containing deliverables for given period

Opening of call online

Validation of the call being opened and made public

Call text

Call text published on the internet provided to the EC

Pubblicazioni

Safety study of Rift Valley Fever human vaccine candidate (DDVax) in mosquitoes

Autori: Corey L. Campbell, Trey K. Snell, Susi Bennett, John H. Wyckoff III, Darragh Heaslip, Jordan Flatt, Emma K. Harris, Daniel A. Hartman, Elena Lian, Brian H. Bird, Mark D. Stenglein, Richard A. Bowen, Rebekah C. Kading
Pubblicato in: WILEY ONLINE LIBRARY, Numero Volume 69, Numero 5, 2022, Pagina/e Pages 2621-2633, ISSN 0000-0000
Editore: WILEY ONLINE LIBRARY
DOI: 10.1111/tbed.14415

Effectiveness of CHIKV vaccine VLA1553 demonstrated by passive transfer of human sera

Autori: Pierre Roques, Andrea Fritzer, Nathalie Dereuddre-Bosquet, Nina Wressnigg, Romana Hochreiter, Laetitia Bossevot, Quentin Pascal, Fabienne Guehenneux, Annegret Bitzer, Irena Corbic Ramljak, Roger Le Grand, Urban Lundberg, Andreas Meinke
Pubblicato in: JCI Insight, Numero Volume 7, Numero14, 2022, ISSN 2379-3708
Editore: JCI Insight
DOI: 10.1172/jci.insight.160173

Safety and immunogenicity of four-segmented Rift Valley fever virus in the common marmoset

Autori: Wichgers Schreur PJ, Mooij P, Koopman G, Verstrepen BE, Fagrouch Z, Mortier D, van Driel N, Kant J, van de Water S, Bogers WM, Punt C, van Keulen L, Verschoor EJ, Kortekaas J.
Pubblicato in: NPJ Vaccines, 2022, ISSN 2059-0105
Editore: NPJ Vaccines
DOI: 10.1038/s41541-022-00476-y

Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo

Autori: Watson-Jones D, Kavunga-Membo H, Grais RF, Ahuka S, Roberts N, Edmunds WJ, Choi EM, Roberts CH, Edwards T, Camacho A, Lees S, Leyssen M, Spiessens B, Luhn K, Douoguih M, Hatchett R, Bausch DG, Muyembe JJ.
Pubblicato in: BMJ Open, Numero 2022, 2022, Pagina/e 12, ISSN 2044-6055
Editore: BMJ Publishing Group
DOI: 10.1136/bmjopen-2021-055596

Single-shot live-attenuated chikungunya vaccine in healthy adults: a phase 1, randomised controlled trial

Autori: Nina Wressnigg, Romana Hochreiter, Oliver Zoihsl, Andrea Fritzer, Nicole Bézay, Anton Klingler, Karen Lingnau, Martina Schneider, Urban Lundberg, Andreas Meinke, Julian Larcher-Senn, Irena Čorbic-Ramljak, Susanne Eder-Lingelbach, Katrin Dubischar, Wolfgang Bender.
Pubblicato in: The Lancet, Numero Volume 20, Numero 10, 2020, ISSN 0140-6736
Editore: The Lancet Publishing Group
DOI: 10.1016/s1473-3099(20)30238-3

Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial

Autori: Martina Schneider, Marivic Narciso-Abraham, Sandra Hadl, Robert McMahon, Sebastian Toepfer, Ulrike Fuchs, Romana Hochreiter, Annegret Bitzer, Karin Kosulin, Julian Larcher-Senn, Robert Mader, Katrin Dubischar, Oliver Zoihsl, Juan-Carlos Jaramillo, Susanne Eder-Lingelbach, Vera Buerger, Nina Wressnigg.
Pubblicato in: The Lancet, Numero VOLUME 401, ISSUE 10394, 2023, ISSN 0140-6736
Editore: The Lancet Publishing Group
DOI: 10.1016/s0140-6736(23)00641-4

È in corso la ricerca di dati su OpenAIRE...

Risultati finali

Pubblicazioni

Condividi questa pagina

Scarica